Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy

Sofosbuvir (SOF) is an HCV NS5B polymerase inhibitor, and GS-331007 is its major metabolite. The aim of this study was to investigate whether clinical and pharmacological factors could influence GS-331007 intracellular (IC) concentrations in peripheral blood mononuclear cells (PBMCs) associated with...

Full description

Bibliographic Details
Main Authors: Jessica Cusato, Lucio Boglione, Amedeo De Nicolò, Gian Paolo Caviglia, Simone Mornese Pinna, Alessia Ciancio, Giulia Troshina, Antonina Smedile, Miriam Antonucci, Valeria Avataneo, Alice Palermiti, Jacopo Mula, Alessandra Manca, Giuseppe Cariti, Marco Cantù, Giorgio Maria Saracco, Giovanni Di Perri, Antonio D’Avolio
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pharmaceuticals
Subjects:
DAAs
single nucleotide polymorphism
pharmacokinetics
<i>ABCB1</i>
<i>ABCG2</i>
<i>HNF4</i>α
Online Access:https://www.mdpi.com/1424-8247/15/3/355

Internet

https://www.mdpi.com/1424-8247/15/3/355

Similar Items